Clinical Trial: Epidemiology, Risk Factors, and Efficacy and Safety of Aztreonam-Avibactam for Complicated Intra-abdominal Infections (cIAI), Hospital-Acquired Pneumonia (HAP), and Ventilator-Associated Pneumonia (VAP) Caused by Carbapenem-Resistant Enterobacteriaceae in Critically Ill Adult Patients in China (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Epidemiology, Risk Factors, and Efficacy and Safety of Aztreonam-Avibactam for Complicated Intra-abdominal Infections (cIAI), Hospital-Acquired Pneumonia (HAP), and Ventilator-Associated Pneumonia (VAP) Caused by Carbapenem-Resistant Enterobacteriaceae in Critically Ill Adult Patients in China'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133607

Registration Time: 2026/09/29

Type: Observational study

Primary Sponsor: The First Affiliated Hospital,Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343127

Published by HT Digital C...